Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial
- Resource Type
- Article
- Authors
- Mazeraud, Aurélien ; Jamme, Matthieu ; Mancusi, Rossella Letizia ; Latroche, Claire ; Megarbane, Bruno; Siami, Shidasp; Zarka, Jonathan; Moneger, Guy; Santoli, Francesco; Argaud, Laurent; Chillet, Patrick; Muller, Gregoire; Bruel, Cedric; Asfar, Pierre; Beloncle, Francois; Reignier, Jean; Vinsonneau, Christophe; Schimpf, Caroline; Amour, Julien; Goulenok, Cyril; Lemaitre, Caroline; Rohaut, Benjamin; Mateu, Philippe; De Rudnicki, Stephane; Mourvillier, Bruno; Declercq, Pierre-Louis; Schwebel, Carole; Stoclin, Annabelle; Garnier, Marc; Madeux, Benjamin; Gaudry, Stéphane; Bailly, Karine; Lamer, Christian; Aegerter, Philippe; Rieu, Christine; Sylla, Khaoussou ; Lucas, Bruno ; Sharshar, Tarek
- Source
- In The Lancet Respiratory Medicine February 2022 10(2):158-166
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2213-2600